Ocular Therapeutix: Q4 Earnings Snapshot
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $15.5 million in its fourth quarter. On a p...
March 7, 2023
12:10 AM
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $15.5 million in its fourth quarter. On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 24 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share. The biotechnology company posted revenue of $14.1 million in the period, which also beat Street forecasts.
Ariana Garcia